The Veterinary Record has published what the British Homeopathy Association is calling the first ever systematic review of randomised controlled trials (RCTs) in veterinary homeopathy.
The review was conducted by Dr Robert Mathie, research development adviser to the association, and Dr Jürgen Clausen from the Carstens Foundation, Germany.
They found 18 placebo-controlled RCTs of veterinary homeopathy, published in the peer-reviewed literature, that were eligible for detailed assessment. Of these, only two were judged to provide reliable evidence. The remainder were unclear or had a high risk of bias.
The two studies which were judged reliable were:
HEKTOEN, L., LARSEN, S., ØDEGAARD, S. A. & LOKEN, T. (2004) Comparison of homeopathy, placebo and antibiotic treatment of clinical mastitis in dairy cows - methodological issues and results from a randomized-clinical trial. Journal of Veterinary Medicine. A, Physiology, pathology, clinical medicine 51, 439-446. In this study, homeopathy was shown to be ineffective.
Dr Mathie said: "Up to now, debates about the efficacy or effectiveness of veterinary homeopathy have been polarised by the absence of any systematic review of the subject. Our work clarifies the nature of the current RCT evidence."
Mr Mark Elliott, immediate past president of the British Association of Homeopathic Veterinary Surgeons, said: "This important study affirms that reliable evidence does exist and that more research should be done, particularly in light of current concerns about antibiotic resistance in production animals."
It seems a remarkable admission, that the entire veterinary homeopathy edifice rests upon one study in piglets. However, if that study did prove the efficacy of homeopathy, it would of course be an order of magnitude more remarkable than today's admission.
So, no pressure then, Camerlink et al!
The British Equine Veterinary Association (BEVA) has clarified regulations on equine dental procedures following a survey which showed confusion, even amongst vets, over who is allowed to do what in a horse's mouth.
In the survey of BEVA members, more than half were unaware of the dentistry techniques that equine dental technicians (EDTs) are permitted to perform and the levels of veterinary supervision required.
In response, the association has put together a new information leaflet which explains the regulations surrounding equine dental care and describes where recommended practice differs from the letter of the law.
All diagnostic and treatment procedures in the horse's mouth are Acts of Veterinary Surgery under the Veterinary Surgeons Act 1966. The only exception is the manual removal of small dental overgrowths and sharp enamel points with hand instruments.
However it is acknowledged that there are a limited number of procedures that, despite being considered Acts of Veterinary Surgery, may be delegated safely to suitably qualified EDTs without compromising the horse's welfare and safety. In 2009 the RCVS, with assistance from BEVA, BVDA and BAEDT, listed these processes and categorised all dental procedures into three groups:
Despite there being no legal basis supporting non-vets performing Category 2 procedures, the RCVS has stated that there would be no public interest in prosecuting vets who collaborate with suitably qualified EDTs to perform non-invasive (Categories 1 and 2) procedures.
BEVA recommends that, for their own protection, all vets who deal with horses:
Vicki Nicholls, equine vet at Wright and Morten in Cheshire, chair of BEVA council's Paraprofessional Committee and member of the British Association of Equine Dental Technicians (BAEDT) said: "The lack of awareness is alarming and clearly emphasises the need to make vets and equine dental technicians fully conscious of current regulations regarding equine dentistry. Non-adherence to the regulations is a serious matter and could lead to prosecution of the veterinary surgeon, EDT and/or owner."
The number of vets taking the BEVA/BVDA exam in equine dentistry has increased in recent years with about 15% of those who have passed the exam being vets. BEVA says this is indicative of the growing awareness, amongst owners and vets, of the importance of dental health. It also reflects a desire to develop and demonstrate both practical skills and a theoretical understanding of equine dental care to augment the vet's broader medical knowledge. Expertise in equine dental care has, for many veterinary practices, become a valuable asset.
Copies of the dental regulations information leaflet can be downloaded from the BEVA website at www.beva.org.uk. BEVA also runs regular dentistry CPD courses, details of which can be found on the website.
Image source: Rachel C from Scotland
Guidelines on the examination of rams for breeding have now been officially updated, thanks to the pooled expertise of delegates at a recent Sheep Fertility Workshop, sponsored by Ceva Animal Health, the Sheep Veterinary Society and EBLEX-AHDB.The previous Sheep Veterinary Society guidelines on the examination of rams for breeding were drawn up in 2007. However, the society says that to date, there has been considerable variation in the practice of ram fertility testing amongst sheep vets across the country.
The Sheep Fertility Workshop, which was held in Edinburgh in June 1014, brought together veterinary experts and scientists to discuss the provision of a comprehensive, evidence-based, best practice protocol, with clear recommendations for practitioners on the assessment of rams.Dr Fiona Lovatt, senior vice president of the Sheep Veterinary Society and director of Flock Health Ltd, who coordinated the workshop, said: "The outcome of some active debating was the recognition that various elements of the guidelines needed to be updated in line with currently recognised best practice. One thing that is really essential is that the practising vet is clear as to the reason for the ram PBE and carefully considers how to communicate the findings and their limitations to the ram's owner."
The updated guidelines cover three levels of ram pre-breeding examinations (PBE):
Carol Atkinson, Ceva's reprodAction range marketing manager, said: "We are proud to have supported the workshop, the outcome of which has been some valuable modifications to the guidelines. We now have a robust, practical benchmarking system in place to help ensure consistency of ram fertility and flock health and development."
The workshop was funded by the Sheep Veterinary Society, Ceva Animal Health and EBLEX-AHDB, with contributions in kind from Innovis, Zoetis and Novartis Animal Health.
The guidelines are available to all members of the Sheep Veterinary Society and can be downloaded from www.sheepvetsoc.org.uk, together with two further forms that are available following appropriate training: SVS Ram PBE data collection and SVS Ram certificate. The Sheep Veterinary Society will be holding a series of CPD days for practitioners in advance of next year's breeding season. Further details will be posted on the website shortly.
Public Health England (PHE) is urging veterinary surgeons, nurses, other healthcare professionals and the public to become Antibiotic Guardians by visiting antibioticguardian.com and pledging to make better use of antibiotics, to help make sure they work now and in the future.
The website first asks users to choose whether they would like to make a pledge as a member of the public or as a healthcare professional or leader.
Those who pledge as a Healthcare Professional > Veterinary Practitioner can select one of the following pledges:
Those who pledge as a member of the public can elect to do so as an adult, a family member, a pet owner or a farmer.
The available pledges change according to category and those who respond will be asked if PHE can follow-up to confirm they did keep their pledge.
The campaign forms part of activities that support European Antibiotic Awareness Day (EAAD). Dr Diane Ashiru-Oredope, Lead for EAAD 2014 at Public Health England, said: "Everybody can help to tackle antibiotic resistance and we really urge people to help us do this. There is a lot to be done but we can start by making inroads into inappropriate prescribing.
"There are 2 elements to this. One is that we need patients to not always expect to receive an antibiotic for those self-limiting illnesses which are typically caused by viruses. This generally includes those where the symptoms include coughs, runny noses, muscle aches and fever. And the other is for GPs not to feel pressurised into prescribing antibiotics when they aren't really necessary.
"Community pharmacists and their teams also have a key role and should be seen as the first port of call for many winter illnesses caused by viruses. They can also help to manage patients' expectations by explaining the normal duration of these symptoms, what warning signs to look out for and providing effective over the counter treatments that will help relieve the symptoms.
Nicholas Brown, President at the British Society for Antimicrobial Chemotherapy (BSAC), said: "Recently published research in BSAC's Journal, Journal of Antimicrobial Chemotherapy, confirms that despite government recommendations to reduce prescribing for viral illnesses there are still many GPs who do this. Of course GPs don't want their patients to feel unwell but there are many medicines which are available over-the-counter which can really help to reduce symptoms and make people feel better.
"We want to encourage everyone to self-treat as much as possible when it is safe and appropriate to do so. By using antibiotics only when they are needed we can all help to make sure that we keep our antibiotics working for everyone in the future.
"Antibiotic resistance is one the biggest threats to public health and PHE is delivering 4 key aspects of the 5-year UK strategy to help combat antibiotic resistance. These are improving infection prevention and control practices to reduce the number of infections in patients; optimising prescribing practice, improving professional education, training and public engagement and enabling better access to and use of surveillance data."
Children learn lots of important lessons about life, sickness and death from animals and veterinary practitioners. There seems to be an important role here for the profession to educate adult animal owners why antibiotics need to be used carefully both in pets and in humans.
Bayer Animal Health has launched Back to Basics, a new guide to antibiotic use which focuses on the concerns raised by vets and vet students about antibiotics in a survey carried out by the company.
465 vets and 40 students took part in the survey in March 2014. Of these:
27% of vets admitted that they struggle to know which antibiotic is the most appropriate for a specific condition. This uncertainty was particularly the case if the patient is un-responsive to the vet's first choice antibiotic, or the condition develops to require a new or additional antibiotic choice. Bayer says it is also clear that many vets may not be aware that pradofloxacin is the least likely of the veterinary fluoroquinolones to select for antibiotic resistance,2 as 23% of vet students and 9% of vets said they believe that all antibiotics carry the same risk of selecting for resistance.
The company says Back to Basics is designed to fill the gaps in knowledge identified by the survey. It presents each of the major classes of veterinary antibiotic and details how they work. It also includes an antibiotics 'jargon buster' to help vets and vet students better understand the commonly used measures of antibiotic activity and make more informed decisions about the use of antibiotics in practice.
Bayer has also developed an online self-assessment quiz that allows vets and students to check their knowledge. The quiz and the guide are both available at www.veraflox.co.uk
References
Bayer Animal Health has launched Baytril® Max 100mg/ml Solution for Injection for Cattle and Pigs, which replaces the company's previously animal-specific Baytril Max products.
Bayer says the active ingredient, enrofloxacin, treats bacterial infection by inhibiting the action of bacterial DNA gyrase resulting in bacterial cell death.
In cattle, Baytril Max treats respiratory infections and mastitis caused by enrofloxacin-sensitive Histophilus somni, Mannheimia haemolytica, Pasteurella multocida and Mycoplasma spp., and enrofloxacin-sensitive E. coli respectively.
In pigs, Baytril Max targets bacterial bronchopneumonia caused by enrofloxacin-sensitive Actinobacillus pleuropneumoniae, Pasteurella multocida and complicated by Haemophilus parasuis as a secondary pathogen in pigs.
Bayer advises that vets treating cattle for respiratory infections should inject subcutaneously. Mastitis cases should be treated intravenously and pigs should be injected intramuscularly in the neck muscles, behind the ear.
The development of the Baytril Max product family provides vets with greater treatment flexibility from one solution.
For further information please visit www.noahcompendium.co.uk
Direct Line has revealed the results of a small survey which found that 78% of veterinary surgeons had treated pets for ingesting human medicines in the last year.
100 vets took part in the study, of which 28% reported that they had cases where owners had deliberately given their pet human medication in an attempt to help them. Some vets described incidents of owners believing paracetamol will help conditions like arthritis and limping. In one case an owner gave their cat a quarter of paracetamol every day in an attempt to stop its pain, which instead resulted in the cat dying.
The most common types of medication ingested were:
In total, the veterinary surgeons who took part in the survey reported 243 cases of accidental ingestion of human medicines. The majority (76%) of cases involved dogs. However incidents involving cats, rabbits and guinea pigs were also reported.
The British Safety Council has launched a new qualification to help people who drive as part of their work stay safe on the roads.
According to the organisation, the Level 2 Award in Safe Driving at Work provides work drivers with key knowledge of the hazards and risks associated with driving and equips them with valuable guidance on the measures available for reducing these risks, such as vehicle inspection, behaviour and defensive driving.
According to estimates from the Health and Safety Executive (HSE), up to a third of all road traffic accidents in Britain involve someone involved in work-related activity. In 2013, according to government figures, 1,713 people died on the road, with the total number of casualties standing at 183,670.
The Ofqual-regulated qualification, which is designed to be delivered by employers or training organisations, instructs learners on a range of topics including the particular risks associated with vulnerable road users, such as cyclists and pedestrians, the importance of regular vehicle safety checks and how to adapt driving style in response to changes in driving conditions or the actions of others.
Alex Botha, the British Safety Council's Chief Executive, said: "Driving can be a risky activity, a fact borne out by the high number of injuries and fatalities that occur annually on our roads.
"However, simple steps can be taken by employers and drivers to manage and reduce this risk. Our new Level 2 Award in Safe Driving at Work provides learners with all the essential knowledge to help them stay safe on the roads.
"Learners can expect to leave the qualification with a thorough knowledge of the main risks posed by driving - whether to themselves or other road users - and how to reduce them.
"Once registered with us, employers or training centres deliver the training using the high-quality teaching and student materials provided. Qualifications are assessed through a 45-minute multiple-choice examination that can be either taken online or on paper.
"This is a stand-alone qualification designed for delivery as a short course. It is also well-suited for integration into wider vocational programmes of study or, for example, as part of an induction programme. Students need no former knowledge or experience, so can come from a diverse range of educational and employment backgrounds.
"Safer driving habits should also feed through into workers' personal lives, providing employers with a valuable corporate social responsibility tool to help make our roads safer in and out of work."
Virbac, maker of Pronefra for the management of CKD in cats and dogs, has launched a free app to help interpret patients' urine test results in line with the latest International Renal Interest Society (IRIS) Guidelines.
The app, which is also called Pronefra, is available for download on both the Play store and Apple store.
Simon Boulton MRCVS, Marketing Manager for Companion Animals, said: "Reference ranges supplied by machines and labs are not always appropriate for the renal patient so we wanted to help practices to interpret kidney-specific results quickly and easily in line with the latest recommendations. The Pronefra app was the result. We have received very positive feedback on the app so far and hope it will help practices improve the quality and length of life of their renal patients."
Virbac is also providing further Pronefra practice support materials, include a pet health recording book for clients to aid in compliance and other educational tools for vets, nurses and clients.
Belfast-based Des Thompson MRCVS was presented with the first ever RCVS Queen's Medal by Her Majesty at Buckingham Palace this afternoon.
Des, pictured right showing off the new medal with his wife Rosalie, received two separate nominations for the medal, both citing his decades of active involvement in veterinary politics which includes being president of the RCVS, the British Small Animal Veterinary Association (BSAVA), the Society of Practising Veterinary Surgeons (SPVS) and the Northern Ireland Veterinary Association, among other organisations.
Also cited was his willingness to help other members of the profession, particularly young vets at the beginning of their careers, through his involvement with organisations such as the Young Vet Network in Northern Ireland and the Veterinary Benevolent Fund.
The Queen's Medal was launched in 2013, with the approval of Her Majesty as Patron of the RCVS, and is now the highest award that can be bestowed upon a veterinary surgeon in recognition of a particularly outstanding contribution to the profession. In receiving the medal, Des was joined by Professor Stuart Reid, current RCVS President, Colonel Neil Smith, immediate past President, and Gordon Hockey, RCVS Registrar.
Des said: "It was a complete honour and a wonderful experience to be received by Her Majesty at Buckingham Palace today, and I'm thrilled to have been awarded the RCVS Queen's Medal. Her Majesty was interested to hear about Northern Ireland, and the fact that I've been practising there since I qualified."
Virbac has launched Milpro, a palatable milbemycin / praziquantel-based broad-spectrum wormer for dogs and cats.
Milpro is offered in tablet sizes suitable for dogs, small dogs or puppies, cats and small cats or kittens for ease of dosing. It is presented in 4, 24 and 48 packs.
As an aid to owner education and compliance, packs of Milpro use 'Blippar Augmented Reality'. Owners download the Blippar app and scan the front of a pack of Milpro or a dispensing envelope, whereupon the pack becomes animated and various interactive options appear, including educational videos, a built in reminder system and other product information.
Simon Boulton MRCVS, Marketing Manager for Companion Animals at Virbac, said: "The practice team has a crucial role to play in reminding owners that regular worming is essential for their pet's health. With the introduction of Milpro, we are extending our parasiticide range and offering practices an alternative solution.
"With compliance such an issue, we want to use 21st century communication to help practices to get the message across. The result is the introduction of an interactive element to our packs with the use of the Blippar platform. It enables us to create 'Augmented Reality' experiences through which we can provide comprehensive information to owners in an eye-catching and easily accessible way with the aim of boosting compliance and, ultimately, welfare.
"We believe the combination of the small tablet sizes and the innovative packaging will prove attractive and convenient to owners, making Milpro a successful product for practices".
Practices can also request an interactive waiting room poster which enables owners to watch a video on the poster on the importance of worming.
This year's National Equine Health Survey, conducted by the Blue Cross and supported by Zoetis, has revealed that 20% of owners who claimed to have treated for encysted small redworm (ESRW) used a wormer that was not indicated to treat the parasite.
3,669 horse owners took part in the survey, which was conducted in May 2014. It contained 25 questions on general horse health, care and management and was validated by Professor Josh Slater at the Royal Veterinary College.
Zoetis says the findings suggest that horses are being left at serious risk (untreated, encysted small redworm may develop and emerge en masse from the gut wall, causing diarrhoea and colic with a mortality rate of up to 50%1).
The company is now running an encysted small redworm awareness campaign at www.esrw.co.uk, where owners can test their knowledge before discussing the best treatment options with their vet.
1. Dowdall S.M.J. et al (2002) Veterinary Parasitology 106, 225‑242
The RSPCA is asking veterinary surgeons to take part in a new survey which aims to build a true picture of the scale of the problem of illegally imported puppies being brought into the UK.
Amongst other things, the survey asks what you consider to be the greatest concerns regarding the poor breeding, dealing and illegal import of puppies and what you think can be done to tackle these and the associated problems.
You can take part in the survey here: www.surveymonkey.com/s/QQNBVFV
James Yeates, Chief Veterinary Officer, said: "RSPCA intelligence suggests that there is a growing illegal trade in puppies from other EU countries and is causing serious health and welfare problems. In many cases puppies are dying or becoming seriously ill. Risk factors appear to include being taken from their mothers too early, not being vaccinated and having to endure long journeys in poor conditions.
"However, it's very difficult to get a full view on the scale of the problem as many cases never get reported to the RSPCA. Vets are likely to be the first port of call when a puppy bought by an unsuspecting buyer becomes sick and may be faced with many of these cases - if sadly not all.
"We're interested in hearing from vets to get their evidence from practice and to hear their ideas about how we can tackle the lucrative illegal trade in puppies."
A review of past research papers on the treatment of feline diabetes carried out by Dr Stijn Niessen at the RVC has found that much of the research into the condition was based on low-level evidence, lacked a cooperative approach and, therefore, yielded questionable results.
According to Dr Niessen, current recommendations are often based on previous research studies which used small sample sizes; some included as little as 8 cats. The biggest sample sizes found contained from 50 to 60 cats, but Dr Neissen says that even this isn't a big enough sample size to yield effective results. He says that so-called power calculations, a statistical test performed as part of this new publication, indicate that at least 80-90 animals are needed to accurately compare the effectiveness of different insulin types and other treatments.
Stijn said: "The only way to improve the quality of research and its results is to design and implement well-structured clinical trials, similar to those used by pharmaceutical companies in human medicine.
"This sort of trial can have a powerful impact on a treatment and how it is used. They can more accurately gauge the pros and cons of specific diabetic treatments for cats, helping us pinpoint troublesome side effects as well as identifying the benefits.
"Current research into the condition is sporadic, lacking a long-term vision and not collaborative. A pet owner can, in theory, go to two different vets and get two very different treatments for the same condition. The owner could then go online and find a third way. These treatments aren't necessarily wrong, it is just one vet may have been trained in one methodology and another in a different way. This is why a collaborative approach is so important, so we can end these inconsistencies and can get closer to the actual truth about which way best to treat our feline friends."
For more information, visit: https://www.facebook.com/RVC.Diabetic.Remission.Clinic
A 17-year-old collie cross called Barney picked arguably the best place in the world for an old dog to fall into a canal last Saturday, when it was rescued by one of the teams taking part in the kayaking stage of the Vet Charity Challenge, an event where there were at least 150 vets on hand to help.
Barney had wandered off through an unlocked gate and fallen into the canal where he was spotted by a team from Kruuse UK. They managed to haul the struggling animal onto their kayak and take him down the canal towards a waiting group of vets and nurses. From there he was taken to Drove Vets in Swindon to make a full recovery.
Andrew Groom from Kruuse said, "It was sheer luck that we happened to be paddling past at that point. The poor chap was struggling on the steep banks of the canal and kept slipping back in. He was getting very tired and at risk of drowning, and judging by his gums and heart rate, going into shock."
Karien White from Drove Vets said: "Barney was a bit hypothermic when he was brought into us with a lot of bumps and bruises. We managed to warm him up and get him cleaned and after a little while his tail started wagging and he seemed very happy and friendly."
News of Barney was posted onto a Pewsey Facebook page which helped his worried owners trace him to the vets.
The Vet Charity Challenge took place on Saturday 27th September at St Francis School, Pewsey, near Marlborough, Wiltshire. The day consisted of 50 of teams of four orienteering, cycling and kayaking as well as undertaking mental and physical tasks. The charity raised over £70,000 in its first two years, with this year expected to boost the funds even more.
Gavin Mitchell, from founding sponsors, BCF Technology, said: "We never dreamt that while trying to raise money for our partner charities, that we would end up saving the life of a pet in such a direct fashion. Had Team Kruuse not been passing at that point, the dog would almost certainly have drowned. It highlights the real commitment and passion that the vet profession feels towards helping animals. Through our event we hope to reach out to help even more animals. People can donate directly to Vet Charity Challenge by contacting us via www.vetcharitychallenge.co.uk."
CVS Group has announced that European internal medicine specialist Caroline Kisielewicz MVB CertSAM DipECVIM-CA is joining ChesterGates Veterinary Specialists with effect from 1 October 2014.
Caroline Kisielewicz graduated from University College, Dublin in 2006 and, after working in first opinion small animal practice for two years, completed an ECVIM-residency training programme at the Small Animal Hospital at the University of Glasgow in February 2013.
Most recently she has been working at the Queen Mother Hospital for Animals at the Royal Veterinary College. She is interested in all aspects of small animal internal medicine, particularly emergency medicine, transfusion medicine, immune-mediated diseases and endocrine diseases.
CVS Referral Director, Professor John Innes said: "We are delighted to welcome Caroline to our specialist team at ChesterGates. She is a rising star in internal medicine and I believe it is a measure of CVS' growing reputation for offering a diverse range of career options that we are attracting some of the strongest talent from the specialist vet pool.
"Caroline joins Ellie Mardell and Chris Saul here at ChesterGates to help us to offer an even more comprehensive and user-friendly internal medicine service."
Caroline said: "I was keen to join this excellent multi-disciplinary specialist referral hospital with its dynamic, friendly and close-knit team. Working at ChesterGates gives me the opportunity to provide the highest standard and quality of care and treatment for my patients, clients and their referring vets."
The International Federation on Ageing has published Companion Animals and the Health of Older Persons, a report described as the most extensive literature review to date of research undertaken in the field of companion animals and the health of older people, made possible through an educational sponsorship from Bayer Healthcare.
The report provides a comprehensive literature review into the ways pets contribute to the physical and mental health of individuals and the well-being of our broader society, citing studies which found:
Dr Jane Barratt from the International Federation on Ageing said: "This field of research has important implications across generations and also for the future of our broader society. Many studies have broadly discussed how pets, such as dogs and cats, contribute to health by reducing anxiety, loneliness and depression, but until today, have not yet been published in a single resource. This new report advances our understanding of the value of companion animals in the framework of human health and the broader society."
In the report, investigators acknowledge that the current data on human-companion animal interactions are often predicated on anecdotal evidence and scant qualitative and quantitative data, with poorly-constructed and poorly-controlled study design. This may account in part for the conflicting results found in a number of different studies. Nonetheless, they argue that based on current evidence of considerable positive potential for the health of older individuals, and the associated health and welfare benefits for local communities and societies, more research time and energy should be directed towards this area of research. In particular, they say, there should be much greater involvement from veterinary surgeons, who are well placed to be consulted in studies of companion animals and older people’s attachment, affection and bonding capacities, well-being and social capital.
Ferenc Polz, Head of Bayer Animal Health said: "The therapeutic benefit of companion animals is an area of study attracting increasing interest among health and social science professionals and this sponsored report is yet another example of the life changing potential of human and animal relationships."
The British Small Animal Veterinary Association has announced that it is offering a new, enhanced legal service for its members, in conjunction Harrison Clark Rickerbys.
From 1st October, BSAVA members will be able to benefit from discounted rates and special fixed-fee packages for their personal and professional legal needs.
The BSAVA says that Harrison Clark Rickerbys' specialist team has a vast experience of acting for small animal veterinary practices, as well as referral practices and animal hospitals throughout the UK.
Charlotte Thornton-Smith from Harrison Clark Rickerbys said: "The team is delighted to provide dedicated membership benefits to the BSAVA and keen to work with its members to advise on any of their legal issues. We have a longstanding relationship with the BSAVA which stretches back over twenty years and have substantial experience of acting for veterinary practitioners, both personally and professionally. We very much hope that members of the BSAVA will take advantage of the special packages and discounted rates we are offering."
For more information, visit www.bsava.com
Vétoquinol, makers of Zylkène, a complementary feed for cats and dogs, has launched www.zylkenepet.co.uk, a new website with advice for pet owners about how they can help their pet deal with unsettling situations.
The website offers a behavioural quiz to help identify whether a pet may need help coping with any changes taking place. In addition, the site offers tips and advice from behavioural experts together with guides to helping pets cope with situations such as moving home, the introduction of a new baby or new people, travelling and holidays, coping with kennel and cattery stays and fireworks.
Krystyna Joyce, Product Manager at Vétoquinol, said: 'Owners often give Zylkène when their pet needs a bit of extra support to deal with unusual situations and changes to their routine, but there are also lots of practical things you can do that will improve a pet's experience further during that time. We wanted to make sure that information was readily available through a succinct, user friendly website.'
Avacta Animal Health and the University of Leicester have announced the development of a new, user-friendly electronic system for diagnosing lymphoma in dogs in the early stages, and for remission monitoring.
Marketed as cLBT (canine lymphoma blood test), this is the first test of its kind to track the remission monitoring status of a dog after undergoing chemotherapy. The test detects the levels of two biomarkers, the acute phase proteins C-Reactive Protein and Haptoglobin.
The new test represents the fruits of a collaboration between Avacta and the University of Leicester in which the company collected a substantial library of biological samples, and the University then brought its statistical and data processing techniques to bear.
Alexander Gorban, Professor of Applied Mathematics at the University of Leicester, said: "This was a very interesting project, and Avacta was a very dedicated, focused company, with clear goals and objectives. There were very important and useful ideas and concepts involved in the study, and it was a pleasure to know that our expertise as a department was needed and could be utilised through working alongside Avacta's professional expertise.
"The project was very successful, and we would be very glad to welcome more partnerships of this type as it has also been very beneficial to the reputation of the University of Leicester's Department of Mathematics. The project involved full academic and commercial success, which has included a full academic cycle as well as full software development, which makes it an incredibly diverse project to have worked on."
Chief Scientific Officer at Avacta Animal Health, Kevin Slater, said: "The collaboration we have with the University of Leicester's Department of Mathematics is having a dramatic impact on the types of new tests that we can offer to vets and their owners. We are already widening the application of multivariate analysis to other diseases which commonly affect our pets, and subsequently, this work could also have benefits to human health."
The paper 'Computational diagnosis and risk evaluation for canine Lymphoma' by E.M. Mirkes, I. Alexandrakis, K. Slater, R. Tuli and A.N. Gorban has been published in the academic journal Computers for Biology and Medicine and is available at the following location: http://dx.doi.org/10.1016/j.compbiomed.2014.08.006
Norbrook Laboratories has announced the addition of new indications to its Loxicom (meloxicam) products, two regarding its use in cats, and the other in calves.
Loxicom 5mg/ml solution for injection for dogs and cats is now indicated for the management of post-operative pain in cats. An injection given around the time of surgery can be followed up with a course of Loxicom 0.5 mg/ml oral suspension for cats. Alternatively, for cats where no follow-up oral treatment is possible, for example with feral cats, a larger dose of the injectable formulation can be given at the time of surgery.
Norbrook's EU Veterinary Advisor, Rebekah Dudek MRCVS, said: "Norbrook is pleased to be able to now offer vets two on-licence choices in relation to how they want to use their 5mg/ml meloxicam injection in cats. This gives vets the flexibility they need to be able to deal effectively with the wide variety of cases they see every day."
Loxicom 20mg/ml solution for injection for cattle, pigs and horses has now been licenced for the relief of post-operative pain following dehorning in calves.
Norbrook says that the use of a non-steroidal antiinflammatory drug (NSAID) alongside local anaesthetic has clear benefits for animal welfare, and that use at this time is also shown to offer economic benefits to the farmer, with increased food-conversion efficiency compared to untreated calves1.
Rebekah said: "Dehorning in calves has long been known as a painful procedure, with a negative impact on feed intake in the post-operative period. With our latest licence, Loxicom 20mg/ml can now be used for relief of this potentially economically important post-operative pain in calves."
Reference
Novartis Animal Health has announced the results of a survey of dairy and beef farmers which found that 39% of those who found Bovine Viral Diarrhoea (BVD) present in their herd did not then go on to test for persistently infected (PI) animals.
Any calf born from a BVD persistently-infected cow will be born Persistently Infected with the virus and cannot be cured. As a result, future vaccination of this animal against the virus is rendered ineffective and the affected animal will be a source of the virus, spreading infection within the herd.
With young cattle being the source of PI's and reservoirs of infection within a herd, failure to test, identify and then deal with PI livestock represents the most significant problem facing the industry when trying to eradicate BVD.
Professor Joe Brownlie from the Royal Veterinary College and current chairman of the BVD Scientific and Technical Working Group, said: "Of the 61% of farmers that did do follow up tests for PI's once BVD had been detected in their herd, one third found one or more PI's within the stock holding.
"However, one third of farmers who identified having active BVD infection in their herd then failed to go on and carry out individual animal testing; of those that did, nearly half discovered one or more individual PI's within their herd".
"It just shows that the disease can be hidden, and farmers could be in the dangerous position of potentially missing PI animals that are in their herd; PI's that can continue to spread the BVD virus amongst other cattle and pass on their PI status to any calves they produce. It is hugely important to be thorough and consistent in your testing as part of an agreed herd health plan"
The survey also indicated that action needs to be taken to educate farmers about what to do once BVD and, most significantly, PI's are discovered amongst a herd.
Professor Brownlie said: "There is much evidence from this survey to encourage the industry in how it is tackling this disease, however there is still a great need for clear direction. The survey indicated that 20% of farmers wrongly believe that PI animal's will eventually become non-infective and that 25 % believe that calves born of PI cows will not always have PI calves themselves.
"All of these perceptions are incorrect and can lead to reservoirs of the disease being allowed to remain not only within individual herds, but geographical regions as well; seriously hindering the eradication of the virus in England and Wales".
With nearly half of farmers saying that they talked to vets - their main source of information about BVD - only once or less a year, Professor Brownlie said it is unsurprising that many farmers did not show a greater understanding of BVD beyond biological side effects present in the infected cattle: "About 50% of farmers surveyed were unsure as to what types of tests need to be carried out to detect the infection in their livestock and 32% of respondents were unaware that correct vaccination of livestock against BVD can protect both the cow and unborn calf".
Novartis says that while BVD is still regarded by farmers as one of the top bovine diseases, other health issues such as mastitis and tuberculosis are given much greater attention. This lack of focus on BVD is exacerbated by the lack of sound information of the financial implications of the infection on their herd.
Professor Brownlie said: "The side effects of BVD appear to be overlooked in financial terms, but the infection can severely hinder a herd's financial productivity due to poor health, reduced milk yield and loss of reproductive efficiency.
Caroline Dawson from Novartis Animal Health said:"Perhaps by aiding understanding of the financial cost of the virus, we can encourage farmers to take more proactive steps to combat BVD. As such, I am pleased to announce that that the FAB panel has initiated a follow on project to carry out detailed research with regards to the financial impact of BVD on farms and is due to report findings in the new year".
(Photograph shows, left to right, James Russell MRCVS (McMurtry & Harding), Caroline Dawson (Novartis Animal Health), Tony Brooks (Brighthams Farm), Professor Joe Brownlie(RCVS)
BCF has announced the launch of the wireless Cuattro Slate 4 equine DR system.
BCF says the new system is available with an Automatic Exposure Detection (AED) panel, which means the plate automatically recognises the radiation from the generator, with no need for a sync cable.
Gavin Mitchell from BCF said: "This system now makes the connection from any generator to the plate and from plate to tablet now wireless. This is the new revolution for equine DR. Our rugged tablet design makes it easy to show your client your images. All you need to carry with you is the plate, tablet and generator. So much lighter to transport than previous DR systems and now also easier to move around the horse."
Sarah O'Grady from BCF added: "The powerful Cuattro software is so intuitive to use, allowing you to easily customise how your image looks. A simple three step process to take an image and just one button press to back-up images to PACS or the Cloud, makes the Slate so easy to use. If you are considering upgrading to DR or replacing your old DR system, then make sure you try out the new Slate 4."
For more information, visit www.bcftechnology.com or ask your local Account Manager for a free trial.
The RCVS has published its 2014 Survey of the Veterinary and Veterinary Nursing Professions, a snapshot of the demographics of the profession, and the educational and work status of its members.
The results, which gauge individual views on the current state of the profession, are used to inform the College's future policy and activities.
6,988 veterinary surgeons (27% of the profession), 3,612 registered/listed veterinary nurses (31% of the profession) and 1,792 student veterinary nurses took part in the surveys, which are conducted once every four years by the Institute for Employment Studies.
This year's surveys included a set of questions about 24-hour emergency cover, which contributed to the recent review of the College's guidance in this area, and, for the first time, questions from the government-backed Social Mobility Toolkit, which aim to assess the social background of members of the profession.
Highlights from the survey of veterinary surgeons included:
Highlights from the survey of veterinary nurses included:
Both the Survey of the Veterinary Profession and the Survey of the Veterinary Nursing Profession, together with a report that brings together common themes, can be downloaded from the RCVS publications page.
Zoetis has launched UlcerGold (omeprazole) for the treatment - and prevention of recurrence - of gastric ulcers in horses and foals, presented in a syringe suitable for foals from four weeks of age and horses from 70 to 700kg.
Equine Gastric Ulceration Syndrome (EGUS) is a serious and common condition affecting horses and foals.2,3 Approximately 90% of racehorses, 60% of performance horses, 37% of leisure horses and 50% of foals have been shown to be affected.2,4,5 The condition is associated with injury to the mucosa of the oesophagus, stomach and duodenum, with prolonged exposure to gastric acid thought to be the primary cause.2,3 Risk factors include stress, intense exercise, a high-grain diet, intermittent feeding and illness.2,3 EGUS can have a profound impact on a horse's condition and performance and can ultimately be life threatening, especially in foals.3,5 It is a challenging condition to diagnose as the clinical signs are often vague and not always present.3 Gastroscopy is the only method currently available for a definitive diagnosis and treatment is usually based on acid suppressive therapy to allow ulcer healing.2
UlcerGold is indicated to treat and prevent the recurrence of gastric ulcers in horses, administered once-daily for 28 consecutive days at the full dose of 4mg/kg bodyweight followed by the reduced dose of 1mg/kg bodyweight for a further 28 days.1 It contains omeprazole, a proton pump inhibitor that suppresses gastric acid secretion.1,2 One syringe contains enough UlcerGold for a horse weighing up to 700kg. It can be used for foals as young as four weeks of age that weigh over 70kg and for breeding stallions.
Zoetis says UlcerGold is supported by a comprehensive gastroscope training programme, pricing model, client support and communications plan to ensure that it is a strong asset to veterinary businesses.
Penny McCann, Equine Product Manager, Zoetis UK Ltd, said: "UlcerGold is an exciting addition to our equine POM-V portfolio. We have designed a training, education and business programme to help practices make sure they get the best from our new product, not only in terms of gastric ulceration treatment but also practice health."